Table 2

Trends in characteristics of study participants (2000–2010)

	2000		2005		2010
Description	n	Percent	n	Percent	n	Percent
Total participants	12 023		14 152		16 378
Retirees	NA	NA	3369	23.8	4594	28.1
Demographics
Age (mean; SD)	39	8.7	45	12.0	45	13.7
Gender
Male	9227	76.7	10 945	77.3	13 076	79.8
Female	2796	23.3	3207	22.7	3302	20.2
Cardiovascular profile
High blood pressure*
Yes	3176	26.4	5457	38.6	6451	39.4
Missing	0	0	4	<0.1	4	<0.1
Diabetes†
Yes	396	3.3	838	5.9	1458	8.9
Missing	0	0	0	0	4	<0.1
Hyperlipidaemia‡
Yes	600	5.0	1749	12.4	5499	33.6‡
Missing	0	0	565	4.0	4	<0.1
Acute myocardial infarction
Yes	NA	NA	66	0.5	128	0.8
			50	0.4	301	1.8
Stroke
Yes	66	0.5	130	0.9	188	1.1
Missing	3	<0.1	49	0.4	320	2.0
Anthropometrics
Waist (cm)
Mean (SD)	81.6	11.2	83.9	9.6	86.6	12.3
Missing	0	0	292	2.1	215	1.3
BMI (cm/kg²)
Missing	25	0.2	277	2.0	190	1.2
Normal body weight (<24)	5852	48.7	5317	37.6	6313	38.6
Overweight (24 to <28)	4456	37.1	5972	42.2	6831	41.7
Obese (≥28)	1690	14.1	2586	18.3	3044	18.6
Systolic blood pressure
Missing	0	0	58	0.4	63	0.4
Mean (SD)	121	17.1	122	18.3	125	20.9
Diastolic blood pressure
Mean (SD)	80	12.1	82	11.6	82	11.2

*Self-report or mean blood pressure ≥140 systolic or ≥90 mm Hg diastolic or antihypertensive medication therapy.
†Self-report or fasting glucose ≥7.0 mmol/L or glucose-lowering medication.
‡Self-report or lipid-lowering therapy for year 2000; self-report only for year 2005; self-report or dyslipidaemia (either: total cholesterol ≥5.2 mmol/L or low-density lipoprotein ≥3.4 mmol/L or high-density lipoprotein <1.0 mmol/L or triglycerides ≥1.7 mmol/L) or lipid lowering medication therapy for year 2010.
BMI, body mass index; NA, not available.